Consumers Advised to Stop Consuming Rosabella Brand Moringa Powder Capsules by Ambrosia Brands LLC

The Communicable Diseases Agency (CDA) and Health Sciences Authority (HSA) are aware of a recall in the US of specific lots of Rosabella brand moringa powder capsules by Ambrosia Brands LLC due to the possible contamination by Salmonella in the affected products. So far, seven Salmonellosis cases in the US have been linked to the affected product, with three hospitalisations and no deaths. The Salmonella Newport strain associated with the cases is extensively drug-resistant.

2     The product was listed for sale on some e-commerce platforms in Singapore and has since been taken down following HSA’s instructions to the platform administrators to remove them if the specific lots were found. HSA has also alerted the Health Supplements Industry Association Singapore to inform their members of the affected lots of this product and to stop selling them if they are currently doing so.

3     To date, there are no reported cases in Singapore of extensively drug-resistant Salmonella associated with the consumption of the affected Rosabella brand moringa powder capsules. Salmonellosis is a notifiable disease under the Infectious Diseases Act. CDA has alerted hospitals and is conducting surveillance with them to monitor for potential extensively drug-resistant Salmonella cases. HSA is monitoring if there are any local adverse events relating to this issue.

4     Consumers are advised to immediately stop taking the affected lots of the product and dispose of the product safely by placing them in a sealed bag with general household waste. They should not open the capsules or flush them down toilets and drains. Any surfaces or containers that have come into contact with the product should be carefully cleaned and sanitised to reduce the risk of cross-contamination. Those who are unwell with symptoms of Salmonella infection after consuming Rosabella brand moringa powder capsules should seek medical advice promptly.

5     Extensively drug-resistant Salmonella is resistant to multiple key antibiotics, leading to limited treatment options and increased risk of severe complications. Symptoms of Salmonella infection typically include fever, diarrhoea, nausea, vomiting, and stomach cramps. Symptoms usually develop six to 72 hours after consumption and can last four to seven days. Some people, especially older adults aged 65 and above, pregnant women, and people with weakened immune systems, may experience more severe illnesses that require medical treatment or hospitalisation.

Product Information

6     The affected Rosabella brand moringa powder capsules have been labelled to support sleep, healthy joints and energy level. In general, moringa supplements (derived from Moringa oleifera leaves) are marketed for their vitamins, proteins and antioxidants content. While this brand does not specifically advertise for specific groups, moringa supplements may be used by elderly individuals and pregnant or lactating women as natural supplements.

7     Details of the affected product is as follows: 

Company Name: Ambrosia Brands, LLC. Brand Name: Rosabella Product Description: Moringa capsules, 60 Count bottles. Expiration dates from March to November 2027.       The lot code consists of the middle seven digits of the code printed above the expiration date on the bottom of the bottle.

Affected lots of Rosabella brand moringa powder capsules recalled in the US:

S/N	Lot codes impacted	Expiry date
1	5020591	03/2027
2	5020592	03/2027
3	5020593	03/2027
4	5020594	03/2027
5	5020595	03/2027
6	5020596	03/2027
7	5030246	04/2027
8	5030247	04/2027
9	5030248	04/2027
10	5030249	04/2027
11	5030250	04/2027
12	5030251	04/2027
13	5040270	05/2027
14	5040271	05/2027
15	5040272	05/2027
16	5040273	05/2027
17	5040274	05/2027
18	5040275	05/2027
19	5040276	05/2027
20	5040277	05/2027
21	5040278	05/2027
22	5040279	05/2027
23	5050053	06/2027
24	5050054	06/2027
25	5050055	06/2027
26	5050056	06/2027
27	5060069	07/2027
28	5060070	07/2027
29	5060071	07/2027
30	5060072	07/2027
31	5060073	07/2027
32	5060074	07/2027
33	5060075	07/2027
34	5060076	07/2027
35	5060077	07/2027
36	5060078	07/2027
37	5060079	07/2027
38	5060080	07/2027
39	5080084	09/2027
40	5080085	09/2027
41	5080086	09/2027
42	5090107	10/2027
43	5090108	10/2027
44	5090109	10/2027
45	5090113	10/2027
46	5090114	10/2027
47	5090115	10/2027
48	5090116	10/2027
49	5090117	10/2027
50	5090118	10/2027
51	5100039	11/2027
52	5100048	11/2027

 

 

COMMUNICABLE DISEASES AGENCY
HEALTH SCIENCES AUTHORITY
SINGAPORE
1 MARCH 2026

Download pdf version here

 

Published: 1 Mar 2026

Subscribeto stay up to date with HSA news and regulatory updates.

Press Releases